About
At SpectroCor Ltd, we are transforming open-heart surgery with our innovative technology that uses in-the-tissue spectrometry in real time. Our device monitors myocardial oxygenation and helps the surgeons to plan and verify adequate heart protection. With about 2 million patients undergoing open-heart procedures annually, our innovation offers quality control and enhanced outcomes, offering surgeons greater precision, while the society benefits from reduced intensive care demands.
Technologies
Outlook
Microsoft Office 365
WordPress.org
Mobile Friendly
Wordpress.com
Nginx
Circle
Keywords
optical spectroscopy
open heart surgery
oximetry
heart surgery
organ transplant
medical sensor
cardioplegia
medical devices
medical equipment manufacturing
in-tissue spectroscopy
spectroscopy in cardiac care
real-time myocardial oxygen monitoring
optical tissue measurement
wide spectrum tissue spectroscopy
healthcare technology
clinical decision support
regulatory compliance
biomedical engineering
intraoperative monitoring
spectroscopy sensors
services
medical device development
advanced myocardial management
medical technology
cytochrome c-oxidase analysis
cardiac surgery technology
spectroscopy-based medical device
real-time intraoperative data
myocardial protection
heart tissue oxygen levels
Company Information
-
Employees 3
-
Founded 2020
Location
5 Otakaari, Espoo, Finland, 02150
